AstraZeneca, a British pharmaceutical giant, has admitted that its Covid-19 vaccine can result in a rare side effect known as Thrombosis with Thrombocytopenia Syndrome (TTS). This acknowledgement follows a lawsuit filed against the company, alleging serious harm and deaths linked to the vaccine.

According to court documents, Covishield, a vaccine developed by AstraZeneca and Oxford University and manufactured by the Serum Institute of India, can, in rare instances, lead to this condition. This vaccine was extensively administered throughout India during the Covid-19 pandemic.